双海岸自发冠状动脉剖析:一个治疗困境
Ann B Nguyen Pham1, Madushka Y De Zoysa2, Brian B Ghoshhajra3
1Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California.
AJP reports
|January 25, 2024
概括
与怀孕相关的自发冠状动脉解剖 (P-SCAD) 是罕见的,具有挑战性的. 这一案例凸显了在怀孕期间需要多学科护理和普遍的心脏查,以更好地管理.
科学领域:
- 心脏病学 心脏病学
- 产科 产科 产科 产科 产科
- 孕产妇健康 孕产妇健康
背景情况:
- 与怀孕相关的自发冠状动脉剖析 (P-SCAD) 存在对孕产妇发病率和死亡率的风险.
- 怀孕期间P-SCAD的管理指南基于专家的共识,因为它很罕见.
- 现有的建议支持在医学上必要时在怀孕期间进行冠状动脉干预,但临床犹仍然存在.
研究的目的:
- 呈现P-SCAD在怀孕期间和产后发生的独特病例.
- 讨论管理P-SCAD的复杂性,包括跨大陆的护理协调.
- 强调在P-SCAD管理中多学科方法和选的重要性.
主要方法:
- 一个38岁的妇女在怀孕28周时出现P-SCAD的病例报告.
- 在产后9天发生P-SCAD复发的记录.
- 讨论临床管理挑战和护理协调.
主要成果:
- 患者在怀孕期间经历了P-SCAD,以及产后复发.
- 该案涉及复杂的后勤挑战,因为患者在最初的事件中不在家.
- 这起案件引发了关于产前急性冠状动脉综合征 (ACS) 管理的关键问题.
结论:
- 多学科护理,特别是涉及心脏-产科团队,对于管理P-SCAD至关重要.
- 应该考虑在怀孕期间进行心脏病的普遍查.
- 这一案例强调了在孕妇中管理P-SCAD的强有力的协议的需要.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


